Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke

Completed

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- age between 30-72 yars,
- < one month after stroke,
- ischemic cerebral stroke,
- signed informed consent form.

Exclusion Criteria

- treatment with thrombolytic after stoke,
- ischemic stroke combined with hemorrhage, severe renal or liver failure, dementia, psychosis and history of seizure disorder, history of previous stroke, and hemoglobin level less than 10mg/dl on admission.